After finishing at $1.82 in the prior trading day, Fortress Biotech Inc (NASDAQ: FBIO) closed at $1.68, down -7.69%. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 564245 shares were traded.
Ratios:
Our goal is to gain a better understanding of FBIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 4.44 whereas as Long-Term Debt/Eq ratio is at 3.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on August 04, 2022, initiated with a Buy rating and assigned the stock a target price of $6.
On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.
On December 18, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $9.B. Riley FBR initiated its Buy rating on December 18, 2019, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 05 ’24 when ROSENWALD LINDSAY A MD bought 50,000 shares for $2.38 per share. The transaction valued at 118,770 led to the insider holds 2,863,905 shares of the business.
ROSENWALD LINDSAY A MD bought 1,567,515 shares of FBIO for $2,664,776 on Nov 14 ’23. The President, CEO & Chairman now owns 2,597,440 shares after completing the transaction at $1.70 per share. On Nov 14 ’23, another insider, WEISS MICHAEL S, who serves as the insider of the company, bought 147,058 shares for $1.70 each. As a result, the insider paid 249,999 and bolstered with 1,130,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 31.06M and an Enterprise Value of 28.90M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.38 while its Price-to-Book (P/B) ratio in mrq is 0.06. Its current Enterprise Value per Revenue stands at 0.36 whereas that against EBITDA is -0.18.
Stock Price History:
Over the past 52 weeks, FBIO has reached a high of $12.75, while it has fallen to a 52-week low of $1.24. The 50-Day Moving Average of the stock is 1.9822, while the 200-Day Moving Average is calculated to be 4.5155.
Shares Statistics:
The stock has traded on average 523.33K shares per day over the past 3-months and 301.49k shares per day over the last 10 days, according to various share statistics. A total of 18.38M shares are outstanding, with a floating share count of 13.35M. Insiders hold about 27.33% of the company’s shares, while institutions hold 25.07% stake in the company. Shares short for FBIO as of Feb 29, 2024 were 1.54M with a Short Ratio of 2.94, compared to 1.49M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.38% and a Short% of Float of 9.56%.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$2.34 for the current quarter, with a high estimate of -$2.08 and a low estimate of -$2.61, while EPS last year was -$4.46. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$6.65 and -$9.85 for the fiscal current year, implying an average EPS of -$8.25. EPS for the following year is -$3.2, with 2 analysts recommending between -$0.4 and -$6.
Revenue Estimates
2 analysts predict $15.07M in revenue for the current quarter. It ranges from a high estimate of $15.69M to a low estimate of $14.46M. As of the current estimate, Fortress Biotech Inc’s year-ago sales were $16.4M, an estimated decrease of -8.10% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $21.5M, an increase of 73.00% over than the figure of -$8.10% in the same quarter last year. There is a high estimate of $21.5M for the next quarter, whereas the lowest estimate is $21.5M.
A total of 2 analysts have provided revenue estimates for FBIO’s current fiscal year. The highest revenue estimate was $80.26M, while the lowest revenue estimate was $53.28M, resulting in an average revenue estimate of $66.77M. In the same quarter a year ago, actual revenue was $75.74M, down -11.80% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $72.52M in the next fiscal year. The high estimate is $80.85M and the low estimate is $64.19M. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
